Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

NordiNet® International Outcome Study-Observational Prospective Study on Patients Treated With Norditropin®

NCT00960128 is registered in ClinicalTrials.gov with Novo Nordisk A/S as lead sponsor.

NCT NCT00960128
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00960128 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
NordiNet® International Outcome Study-Observational Prospective Study on Patients Treated With Norditropin®
Lead sponsor
Novo Nordisk A/S
Phase
Observational
Overall status
Completed
Start date
April 1, 2006
Completion date
December 31, 2016
Enrollment
21,249 (actual)
Sites
23

Conditions

As the registry lists them; a condition with its own page is linked.

adult growth hormone deficiency, chronic kidney disease, chronic renal insufficiency, foetal growth problem, genetic disorder, growth hormone deficiency in children, growth hormone disorder, noonan syndrome, small for gestational age, turner syndrome